<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010014873">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACLN : Articles dans des revues avec comité de lecture non répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="bold" font="default" size="100%">Chippaux, Jean-Philippe</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Bouchité, Bernard</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Boussinesq, Michel</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Ranque, Sophie</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Baldet, Thierry</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Demanou, M.</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Impact of repeated large scale ivermectin treatments on the transmission of Loa loa</title>
        <secondary-title>Transactions of the Royal Society of Tropical Medicine and Hygiene</secondary-title>
      </titles>
      <pages>454-458</pages>
      <keywords>
        <keyword>LOASE</keyword>
        <keyword>ENDEMIE</keyword>
        <keyword>TRAITEMENT MEDICAL</keyword>
        <keyword>VECTEUR</keyword>
        <keyword>DYNAMIQUE DE POPULATION</keyword>
        <keyword>INFECTION</keyword>
        <keyword>PREVALENCE</keyword>
        <keyword>IVERMECTINE</keyword>
        <keyword>CHIMIOTHERAPIE DE MASSE</keyword>
        <keyword>CAMEROUN CENTRE</keyword>
        <keyword>NGAT</keyword>
      </keywords>
      <dates>
        <year>1998</year>
      </dates>
      <call-num>fdi:010014873</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Transactions of the Royal Society of Tropical Medicine and Hygiene</full-title>
      </periodical>
      <isbn>0035-9203</isbn>
      <number>4</number>
      <electronic-resource-num>10.1016/S0035-9203(98)91091-4</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010014873</url>
        </related-urls>
        <pdf-urls>
          <url>https://horizon.documentation.ird.fr/exl-doc/pleins_textes/pleins_textes_7/b_fdi_51-52/010014873.pdf</url>
        </pdf-urls>
      </urls>
      <volume>92</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>We have studied the impact of large-scale treatment with ivermectin on the transmission of loiasis in a forest village in south Cameroon where loiasis was highly endemic, with a prevalence of 30%. After one year of parasitological and entomological surveillance without treatment, all consenting residents aged &gt; 5 years received ivermectin 200 microg/kg every 3 months. For ethical reasons, treatment was interrupted after 2 years, but parasitological and entomological surveillance continued for 18 months after the end of treatment. The prevalence of loiasis was reduced to &lt; 10% and the mean microfilaraemia decreased by 90% in 2 years. The prevalence and average intensity of infection remained stable during the 18 months after treatment ended. Two vector species were identified, #Chrysops dimidiata$ (representing about 90% of the fly population) and #C. silacea$. The infection rate (all stages) in #Chrysops$ decreased by 75% and the infective rate (percentage of #Chrysops$ harbouring third-stage larvae of #Loa loa$ in the head) decreased by 85% in #C. dimidiata$ and became zero in #C. silacea$. After the end of treatment, the infection and infective rates increased gradually. Large-scale treatment seemed an efficient method for the control of #L. loa$ transmission provided high drug coverage was achieved. Nevertheless, because of the high risk of adverse effects when using the current microfilaricidal drugs, such a strategy remains unacceptable. (Résumé d'auteur)</abstract>
      <custom6>052MALTRA05</custom6>
    </record>
  </records>
</xml>
